Many people require a combination of treatments ... has approved it to improve wakefulness in adults with EDS associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder ...
The CDC recommends 7 or more hours of nightly sleep for adults ... its treatments may be helpful. For more pervasive anxiety, seeing a therapist or psychologist may be helpful. Since narcolepsy ...
Xywav is the only liquid medicine approved to treat both narcolepsy and idiopathic hypersomnia. which is safe and effective for adults. Parasomnias are disruptive sleep disorders that can occur ...
Elsewhere in the narcolepsy field, Alkermes has commenced the Phase II Vibrance-2 clinical trial of ALKS 2680 in adults with narcolepsy ... trial of LUMRYZ for the treatment of idiopathic hypersomnia.
The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...
The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.